Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman

"The heart of the Corcept case is a classic 'information gap' between what the company told the public and what the FDA was reportedly telling the company behind closed doors," said Reed Kathrein, the ...

3 Reasons to Avoid CORT and 1 Stock to Buy Instead

Shareholders of Corcept would probably like to forget the past six months even happened. The stock dropped 56.3% and now ...

Corcept Therapeutics (CORT) Climbs 19.7% as Lifyorli Gets FDA OK

Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the 10 Stocks Investors Are Buying Now. Corcept Therapeutics rallied for a ...
Morningstar

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive ...
PharmiWeb

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...